Restless leg syndrome (RLS) is common in patients with cirrhosis, but its treatment in such patients remains unclear. This pilot study assessed the clinical effectiveness of intravenous iron and a… Click to show full abstract
Restless leg syndrome (RLS) is common in patients with cirrhosis, but its treatment in such patients remains unclear. This pilot study assessed the clinical effectiveness of intravenous iron and a 6‐week course of low‐dose (75 mg/day) pregabalin for the treatment of RLS in patients with cirrhosis.
               
Click one of the above tabs to view related content.